Blue Horizon

Blue Horizon is an impact investment firm focused on accelerating the global transition to a sustainable food system. Operating at the intersection of biology, technology, and agriculture, the firm deploys capital across the full lifecycle of food innovation — from early-stage seed investments to growth-stage roll-ups and mature company scaling. Its investment philosophy, which it calls 'Double Positive,' is built on the premise that measurable positive impact for the planet, humans, and animals is fully compatible with — and mutually reinforcing of — above-market financial returns for investors. Blue Horizon has funded more than 100 companies to date, with a notable emphasis on diversity, as 53% of its funded founders are female. The firm has backed three unicorns and targets greater than 10x market penetration by alternative proteins by 2035. The company's investment scope deliberately extends beyond alternative proteins alone. It takes a holistic view of the sustainable food value chain, encompassing better crop and agricultural practices, food technology and science, sustainable packaging innovations, and smarter distribution systems. This comprehensive lifecycle approach allows Blue Horizon to support transformative change at every node of the food system, rather than focusing narrowly on any single category. The firm backs mission-aligned founders and entrepreneurs — described internally as 'mavericks and mavens' — who are working to drive mass adoption of sustainable food alternatives. Blue Horizon believes these sustainable options will outperform their conventional counterparts, making systemic change not only possible but inevitable within the decade. Its team combines serial entrepreneurship with deep scientific expertise, positioning it uniquely to identify, champion, and scale the companies most likely to reshape global food systems by 2050.